Transgenic Models of Pancreatic Cancer
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Tan X, Yang Z, Yang L, Miao X World J Surg Oncol. 2014; 12:32.
PMID: 24502441 PMC: 3931407. DOI: 10.1186/1477-7819-12-32.
Liao J, Adsay N, Khannani F, Grignon D, Thakur A, Sarkar F Histol Histopathol. 2007; 22(6):661-76.
PMID: 17357096 PMC: 3882316. DOI: 10.14670/HH-22.661.
Liao D, Wang Y, Wu J, Adsay N, Grignon D, Khanani F J Carcinog. 2006; 5:19.
PMID: 16822304 PMC: 1559682. DOI: 10.1186/1477-3163-5-19.
References
1.
Brembeck F, Moffett J, Wang T, Rustgi A
. The keratin 19 promoter is potent for cell-specific targeting of genes in transgenic mice. Gastroenterology. 2001; 120(7):1720-8.
DOI: 10.1053/gast.2001.24846.
View
2.
Corbett T, Roberts B, Leopold W, Peckham J, WILKOFF L, Griswold Jr D
. Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice. Cancer Res. 1984; 44(2):717-26.
View
3.
Cerny W, Mangold K, Scarpelli D
. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res. 1992; 52(16):4507-13.
View
4.
Warshaw A, Fernandez-Del Castillo C
. Pancreatic carcinoma. N Engl J Med. 1992; 326(7):455-65.
DOI: 10.1056/NEJM199202133260706.
View
5.
Mueller R, Krahl T, Sarvetnick N
. Tissue-specific expression of interleukin-4 induces extracellular matrix accumulation and extravasation of B cells. Lab Invest. 1997; 76(1):117-28.
View